Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 841 of 1,261
  1. US 8592384

    Micro-RNA's that regulate muscle cells

    The Board of Regents of the University of Texas System · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  2. US 8592386

    Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis

    Sarepta Therapeutics, Inc. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  3. US 8592402

    Compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  4. US 8591862

    Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  5. US 8592452

    Cyclic amine compound

    Takeda Pharmaceutical Company Limited · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  6. US 8592442

    Nilotinib HCl crystalline forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  7. US 8592431

    Fused ring compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  8. US 8592389

    MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

    Julius-Maximilians-Universitat Wurzburg · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  9. US 8592379

    Metastin derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  10. US 8591891

    Monoclonal antibodies against ANGPTL4

    LEXICON PHARMACEUTICALS, INC. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  11. US 8591950

    Hydrogel implants with varying degrees of crosslinking

    Covidien LP · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  12. US 8591929

    Hydrogel implants with varying degrees of crosslinking

    Covidien LP · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  13. US 8591964

    Vaccinium species compositions

    Denali Biotechnologies, Inc. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  14. US 8591922

    Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

    Jazz Pharmaceuticals, Inc. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  15. US 8591889

    Human monoclonal antibodies specific for CD22

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  16. US 8592380

    Aerosol foams comprising clindamycin phosphate

    Precision Dermatology, Inc. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  17. US 8592570

    Compositions and methods for inhibiting expression of an RNA from West Nile virus

    Alnylam Pharmaceuticals, Inc. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  18. US 8592602

    Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

    Vertex Pharmaceuticals Incorporated · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  19. US 8592598

    Method of producing a crystal of an imidazole compound

    Takeda Pharmaceutical Company Limited · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  20. US 8592597

    Pyrrole compounds

    Takeda Pharmaceutical Company Limited · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  21. US 8592596

    Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

    Theravance, Inc. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  22. US 8592577

    Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  23. US 8592571

    RNAi modulation of APOB and uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  24. US 8592464

    Nitric oxide furoxan derivative compounds endowed with antitumoral activity

    HUMANITAS MIRASOLE S.P.A. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.